Summary
This prediction ended on 07.04.25 with a price of €19.25. The price of Bayer AG decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.49%. RevenueInsolvency22 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | 3.464% | 3.464% | 99.853% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by RevenueInsolvency22 for this prediction
In the thread Trading Bayer AG
Die von RevenueInsolvency22 gewählte maximale Laufzeit wurde überschritten